Search:
  • Ranking
  • Beyond the horizon 
  • Not recommended
  • Mapping
  • CTR
  • CLA
  • Due diligence
  • Leadership team
  • Marketing materials
  • Purchase plans
  • Contact
  • log in
  • Free trial access
  • Search
    • Competitive Emerging Technology Reports (CTRs)
    One of the primary services of the MedInvest Scanner is the provision of competitive emerging technology reports, so called CTRs. As a result of a landscape investigation, we can inform you not only of technologies already on the market but also of those which are beyond the horizon.

    A Competitive Emerging Technology Report embraces information which can be gathered at a given time in order to further decrease your investment risk. There is no better source. Through utilizing the CTR, it is possible to reduce investment risk to the level of only 5 to 10%.

    First we conduct horizon scanning and perform critical appraisal of available scientific evidence. The CTR contains information concerning the competitive environment and alternative market access strategies of upcoming products. Within the analyses, we assess the innovativeness of a given medical product along with its added-value compared to current and prospective treatment or diagnostic options.

    Most of all, within CTR, MedInvest Scanner will provide you with information on expected prices of technologies entering the market in the 2 to 3 upcoming years, due to Value Based Pricing criteria. CTR also embraces evaluation of budget impact in a given market segment in selected countries. It takes about 3 months to develop full CTR.

    If time is limited but also as a preliminary analysis one can be interested in a rapid CTR. Rapid CTR (rCTR) embraces simplified analysis similar to full CTR. It provides quick insight to a landscape but with higher uncertainty around estimates due to time constrains. rCTR is usually delivered in one month.

    Here examples of CTR and rCTR can be downloaded:

    Rapid CTR Illumina MiSeqDx

    CTR HeartFlow

    CTR HeartFlow - short

    M.I.S. access plans
    Rapid competitive emerging technology report (rCTR) rCTR (rapid) – a brief report presenting a rapid assessment of a given health technology's competitive potential, performed for a fee, commissioned by the Client and delivered in the form of an MS Power Point presentation; upon the Client's explicit wish and for an additional negotiable fee – also in the form of an MS Word document. Detailed conditions, including the anticipated subject and scope of the report are each time determined by the Parties in a separate written agreement. Rapid CTR costs 11,100 USD*. Click to order
    Full competitive emerging technology report (CTR) CTR (full) – a full report on assessment of competitive potential of a given health technology performed for a fee and commissioned by the Client based on the rCTR (rapid) previously commissioned by the Client and prepared for the same health technology and the same indication. CTR (full) includes information on expected prices of technologies "beyond the horizon" (3-5 years before their registration or marketing authorisation in the European Union and the USA) and determines the budget impact of these technologies in the given market segment. CTR (full) is delivered to the Client in the form of an MS Power Point presentation and upon his/her explicit wish and for an additional negotiable fee – also in the form of an MS Word document. Detailed conditions, including the anticipated subject and scope of the report are each time determined by the Parties in a separate written agreement. Full CTR costs 35,000 USD*. Click to order
    Customized landscape analysis (CLA) CLA – a report presenting an assessment of competitive potential in a given market segment for a chosen health technology or a group of health technologies performed for a fee, commissioned by the Client and delivered in the form of an MS Power Point presentation and (upon his/her explicit wish and for an additional negotiable fee) also in the form of an MS Word document. The CLA report does not provide information on expected prices of competitive technologies at the early stage of research and development nor does it contain information on the budget impact they can cause upon entering the market. Detailed conditions, including the anticipated subject and scope of the report are each time determined by the Parties in a separate written agreement. The price of CLA is 12,000 USD* net for a bold report in a MS Word format and 20,000 USD* if it is also going to be presented to the client in the format of MS Power Point – the presentation will be held in the premises of the client or another agreed location. Click to order
    Short report of competitive space (SRCS) SRCS – a brief report pertaining to a competitive market segment for a particular health technology or a group of health technologies, based on the M.I.S. database, including an overview of competitive technologies entered into the M.I.S. database and their place in the Ranking as compared to the health technology which is the subject of the ordered SRCS. Detailed conditions, including the anticipated subject and scope of the report are each time determined by the Parties in a separate written agreement. SRCS costs 3,000 USD*. Click to order
    *The descriptions of services and products offered by MedInvest Scanner sp. z o.o and their prices are presented here for informational purposes only and do not constitute an offer within the meaning of the applicable provisions of law, and in particular do not constitute an offer within the meaning of Article 66 paragraph 1 of the Civil Code. MedInvest Scanner sp. z o.o reserves the right to change the scope of services and products it offers as well as their prices.